July 22, 2020

Fathom Chart of the Day 22.07.2020 News on COVID-19 vaccine and treatment helps buoy stock markets

by Fathom Consulting.

This week has brought news of promising results from several clinical trials. A study published in The Lancet on Monday revealed that a vaccine, jointly developed by Oxford University and AstraZeneca, had performed well in the first phase of testing, producing a dual immune response in its patients (T-cells within 14 days of vaccination and antibodies after 28 days). Another study, based in China and also covered by the Lancet article, had similar results. Meanwhile, shares in respiratory drug developer Synairgen gained more than 400% following news that its inhalation treatment reduced the likelihood of developing severe symptoms in COVID-19 patients by almost 80%.

Refresh this chart in your browser | Edit the chart in Datastream

This chart is taken from Fathom’s Recovery Watch newsletter. Click here to subscribe to Recovery Watch and Forums.

Next forum date: Monday 27 July 2020



Financial time series database which allows you to identify and examine trends, generate and test ideas and develop view points on the market.

Refinitiv offers the world’s most comprehensive historical database for numerical macroeconomic and cross-asset financial data which started in the 1950s and has grown into an indispensable resource for financial professionals. Find out more.

Get In Touch


We have updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.×